mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.3 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.3 |
mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.3 |